Other kinases, such as Glycogen synthase kinase‐3 beta (GSK3β) and Protein kinase C alpha (PKCα) were found to be overexpressed in ALS and AD cases, respectively, and TANK binding kinase 1 (TBK1) and NIMA‐related kinase 1 (NEK1) loss‐of‐function mutations were identified in ALS patients, however these kinases have no direct link to TDP‐43 phosphorylation [61, 101, 102, 103]. Here, PRKCA is linked to Alzheimer disease.